Grupo Oftalmo-Biología Experimental
Hospital General Universitario de Valencia
Valencia, EspañaPublicaciones en colaboración con investigadoras/es de Hospital General Universitario de Valencia (9)
2020
-
Adalimumab in Elderly Patients with Non-Infectious Uveitis. Safety and Efficacy
Ocular Immunology and Inflammation, pp. 1-8
-
Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study Group
Ophthalmology
2019
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089
2018
2017
-
Development of an activity disease score in patients with uveitis (UVEDAI)
Rheumatology International, Vol. 37, Núm. 4, pp. 647-656
2015
-
Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
Journal of Ophthalmology, Vol. 2015
2014
-
A Delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration
Journal of Ophthalmology, Vol. 2014
-
AB0571 High Dose Intravenous Methylprednisolone Induces RAPID Improvement in Severe Ocular Inflammation. Multicenter Study of 104 Cases
Annals of the Rheumatic Diseases, Vol. 73, Núm. Suppl 2, pp. 995.1-995
2009
-
Beneficial effect of docosahexanoic acid and lutein on retinal structural, metabolic, and functional abnormalities in diabetic rats
Current Eye Research, Vol. 34, Núm. 11, pp. 928-938